These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 17115239)
1. MTHFR polymorphism and bone mineral density: meta-analysis of published studies. Riancho JA; Valero C; Zarrabeitia MT Calcif Tissue Int; 2006 Nov; 79(5):289-93. PubMed ID: 17115239 [TBL] [Abstract][Full Text] [Related]
2. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study. Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333 [TBL] [Abstract][Full Text] [Related]
3. Association of plasma folate, plasma total homocysteine, but not methylenetetrahydrofolate reductase C667T polymorphism, with bone mineral density in postmenopausal Iranian women: a cross-sectional study. Golbahar J; Hamidi A; Aminzadeh MA; Omrani GR Bone; 2004 Sep; 35(3):760-5. PubMed ID: 15336613 [TBL] [Abstract][Full Text] [Related]
5. Are effects of MTHFR (C677T) genotype on BMD confined to women with low folate and riboflavin intake? Analysis of food records from the Danish osteoporosis prevention study. Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L Bone; 2005 Mar; 36(3):577-83. PubMed ID: 15777680 [TBL] [Abstract][Full Text] [Related]
6. Association of the C677T polymorphism in the MTHFR gene with migraine: a meta-analysis. Rubino E; Ferrero M; Rainero I; Binello E; Vaula G; Pinessi L Cephalalgia; 2009 Aug; 29(8):818-25. PubMed ID: 17714520 [TBL] [Abstract][Full Text] [Related]
7. Association of MTHFR C667T polymorphism with bone mineral density and fracture risk: an updated meta-analysis. Wang H; Liu C Osteoporos Int; 2012 Nov; 23(11):2625-34. PubMed ID: 22187009 [TBL] [Abstract][Full Text] [Related]
8. Analysis of three functional polymorphisms in relation to osteoporosis phenotypes: replication in a Spanish cohort. Agueda L; Urreizti R; Bustamante M; Jurado S; Garcia-Giralt N; Díez-Pérez A; Nogués X; Mellibovsky L; Grinberg D; Balcells S Calcif Tissue Int; 2010 Jul; 87(1):14-24. PubMed ID: 20390408 [TBL] [Abstract][Full Text] [Related]
9. Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Macdonald HM; McGuigan FE; Fraser WD; New SA; Ralston SH; Reid DM Bone; 2004 Oct; 35(4):957-64. PubMed ID: 15454103 [TBL] [Abstract][Full Text] [Related]
10. Maternal and offspring MTHFR gene C677T polymorphism as predictors of congenital atrial septal defect and patent ductus arteriosus. Zhu WL; Li Y; Yan L; Dao J; Li S Mol Hum Reprod; 2006 Jan; 12(1):51-4. PubMed ID: 16373366 [TBL] [Abstract][Full Text] [Related]
11. Methylenetetrahydrofolate reductase C677T polymorphism and the risk of unexplained recurrent pregnancy loss: a meta-analysis. Ren A; Wang J Fertil Steril; 2006 Dec; 86(6):1716-22. PubMed ID: 17074326 [TBL] [Abstract][Full Text] [Related]
12. MTHFR c.677C>T polymorphism as an independent predictor of peak bone mass in Danish men--results from the Odense Androgen Study. Abrahamsen B; Jørgensen HL; Nielsen TL; Andersen M; Haug E; Schwarz P; Hagen C; Brixen K Bone; 2006 Feb; 38(2):215-9. PubMed ID: 16169307 [TBL] [Abstract][Full Text] [Related]
13. Association of TNFSF11 gene promoter polymorphisms with bone mineral density in postmenopausal women. Mencej S; Prezelj J; Kocijancic A; Ostanek B; Marc J Maturitas; 2006 Oct; 55(3):219-26. PubMed ID: 16730419 [TBL] [Abstract][Full Text] [Related]
15. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Villadsen MM; Bünger MH; Carstens M; Stenkjaer L; Langdahl BL Osteoporos Int; 2005 Apr; 16(4):411-6. PubMed ID: 15300362 [TBL] [Abstract][Full Text] [Related]
16. Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia. Golbahar J; Aminzadeh MA; Al-Shboul QM; Kassab S; Rezaian GR Nutr Metab Cardiovasc Dis; 2007 Jul; 17(6):462-7. PubMed ID: 17010581 [TBL] [Abstract][Full Text] [Related]
17. Meta-analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Boccia S; Boffetta P; Brennan P; Ricciardi G; Gianfagna F; Matsuo K; van Duijn CM; Hung RJ Cancer Lett; 2009 Jan; 273(1):55-61. PubMed ID: 18789576 [TBL] [Abstract][Full Text] [Related]
18. Association of the MTHFR C677T polymorphism and bone mineral density in postmenopausal women: a meta-analysis. Li D; Wu J J Biomed Res; 2010 Nov; 24(6):417-23. PubMed ID: 23554658 [TBL] [Abstract][Full Text] [Related]
19. Association between the methylenetetrahydrofolate reductase c.677C>T polymorphism and bone mineral density: an updated meta-analysis. Li HZ; Wang W; Liu YL; He XF Mol Genet Genomics; 2016 Feb; 291(1):169-80. PubMed ID: 26231982 [TBL] [Abstract][Full Text] [Related]
20. Association of the 163A/G and 1181G/C osteoprotegerin polymorphism with bone mineral density. García-Unzueta MT; Riancho JA; Zarrabeitia MT; Sañudo C; Berja A; Valero C; Pesquera C; Paule B; González-Macías J; Amado JA Horm Metab Res; 2008 Mar; 40(3):219-24. PubMed ID: 18348083 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]